Evidence map›Paper›PMID 38791144›Full record

ArticleInternational journal of molecular sciences2024

The Role of Methylation Analysis in Distinguishing Cellular Myxoma from Low-Grade Myxofibrosarcoma.

Hanna Henzinger, Iva Brčić, Jasminka Igrec, Theresa Marie Godschachner, Susanne Scheipl, Joanna Szkandera, Philipp Jurmeister, Bernadette Liegl-Atzwanger

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hanna HenzingerDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.
Iva BrčićDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0001-9847-0171
Jasminka IgrecDivision of General Radiology, Department of Radiology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0003-0247-8393
Theresa Marie GodschachnerDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.ORCID 0009-0001-2295-2622
Susanne ScheiplDepartment of Orthopedics and Trauma, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-6675-7052
Joanna SzkanderaDivision of Clinical Oncology, Department of Medicine, Medical University of Graz, 8010 Graz, Austria.
Philipp JurmeisterInstitute of Pathology, Ludwig Maximilians University Hospital Munich, 80336 Munich, Germany.
Bernadette Liegl-AtzwangerDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0003-2229-5535

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular myxoma is a benign soft tissue tumor frequently associated with

Indexed as

DNA Copy Number VariationsDNA MethylationFibrosarcomaMyxomaAdultAgedAged, 80 and overChromograninsDiagnosis, DifferentialFemaleGTP-Binding Protein alpha Subunits, GsHumansMaleMiddle AgedMutationSoft Tissue NeoplasmsChromograninsGNAS protein, humanGTP-Binding Protein alpha Subunits, Gscellular myxomaGNAS mutationintramuscular myxomamethylation analysismyxofibrosarcoma

Identifiers

PMID38791144
PMCPMC11121712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.